Fourth time in RESPECT Index for Pelion
For a fourth consecutive time, Pelion S.A. has secured a place in the RESPECT Index, again confirming its adherence to the highest standards of responsible and sustainable conduct of business.
The official announcement of the Index review results and presentation of membership certificates took place at the offices of the Warsaw Stock Exchange on December 16th 2015. The 9th edition of the RESPECT Index comprises 23 companies.
They have passed a multi-stage qualification process, involving a thorough assessment of the extent and comprehensiveness of their stakeholder-focused activities. Among the evaluated areas were business management strategies and techniques, HR and environmental policies, as well as market- and customer-oriented initiatives.
Pelion Healthcare Group’s inclusion in the RESPECT Index for the fourth time proves that the company runs its business in a responsible and sustainable manner, and that it meets the expectations of its stakeholders, creating partnerships based on trust and transparency. With a headcount of over 9 thousand, Pelion is particularly committed to its workforce, who are the company’s most important asset, helping it fulfil the mission of patient care.
Another inclusion in the RESPECT Index also confirms the soundness of the company’s core values, which have been the foundation of its everyday activity for 25 years. In accordance with its mission of ‘Long and quality life’, Pelion focuses fully on patients and their needs, providing them with innovative and comprehensive healthcare solutions. Pelion also aims to serve patients with support throughout the process of pharmacotherapy, as well as with expert knowledge, modern solutions in disease prevention and treatment and access to a wide range of affordable medicines.
RESPECT Index is the first index of socially responsible companies (SRI) in Central and Eastern Europe. It includes the most liquid companies, which are market leaders in corporate governance, quality reporting and investor relations, and which stand out for their environmental, social and employee-related performance. New qualifying rules were introduced with the 7th edition of the RESPECT Index. Companies are now assessed from the relevant industry’s perspective, with the main areas of focus being their environmental, social and management performance. In its new form, the Index is also open to foreign companies. The rankings are updated annually, and constituent companies are chosen from among the largest names listed in the WIG20, mWIG40 and sWIG80 indices. The Index represents a valid point of reference for stock market investors, who want to be sure that they invest in highly-liquid companies run to the best-in-class standards of management. In the period from November 19th 2009, when the first RESPECT Index was announced, until December 2014, the Index generated a 70% rate of return.
For further information, please contact:
Pelion S.A. Press Office
Phone: (+48 42) 200 75 94
Fax: (+48 42) 200 75 35
Email: biuro_prasowe@pelion.eu
Pelion S.A. has operated on the market for twenty-five years, starting out as a local pharmaceutical wholesaler. In 1998, the Company shares were floated on the Warsaw Stock Exchange. Proceeds from the initial public offering fuelled the Company’s dynamic growth and allowed it to embark on consolidation of the pharmaceutical wholesale market. Since its flotation, the Company has secured a top position among domestic distributors of medicinal products. Today, Pelion Healthcare is one of the largest groups operating in the healthcare markets in Poland and Lithuania. It provides services across all market segments (wholesale, retail sales and sales to hospitals), targeted at individual patients, pharmacies, hospitals, and manufacturers. As a holding company, Pelion S.A. oversees all areas of the Company’s operations, which are conducted by PGF S.A. and Pharmapoint Sp. z o.o. (wholesale), PGF Urtica Sp. z o.o. (hospital sales), CEPD N.V. (retail sales), and Pharmalink Sp. z o.o. (services for manufacturers).
They have passed a multi-stage qualification process, involving a thorough assessment of the extent and comprehensiveness of their stakeholder-focused activities. Among the evaluated areas were business management strategies and techniques, HR and environmental policies, as well as market- and customer-oriented initiatives.
Pelion Healthcare Group’s inclusion in the RESPECT Index for the fourth time proves that the company runs its business in a responsible and sustainable manner, and that it meets the expectations of its stakeholders, creating partnerships based on trust and transparency. With a headcount of over 9 thousand, Pelion is particularly committed to its workforce, who are the company’s most important asset, helping it fulfil the mission of patient care.
Another inclusion in the RESPECT Index also confirms the soundness of the company’s core values, which have been the foundation of its everyday activity for 25 years. In accordance with its mission of ‘Long and quality life’, Pelion focuses fully on patients and their needs, providing them with innovative and comprehensive healthcare solutions. Pelion also aims to serve patients with support throughout the process of pharmacotherapy, as well as with expert knowledge, modern solutions in disease prevention and treatment and access to a wide range of affordable medicines.
RESPECT Index is the first index of socially responsible companies (SRI) in Central and Eastern Europe. It includes the most liquid companies, which are market leaders in corporate governance, quality reporting and investor relations, and which stand out for their environmental, social and employee-related performance. New qualifying rules were introduced with the 7th edition of the RESPECT Index. Companies are now assessed from the relevant industry’s perspective, with the main areas of focus being their environmental, social and management performance. In its new form, the Index is also open to foreign companies. The rankings are updated annually, and constituent companies are chosen from among the largest names listed in the WIG20, mWIG40 and sWIG80 indices. The Index represents a valid point of reference for stock market investors, who want to be sure that they invest in highly-liquid companies run to the best-in-class standards of management. In the period from November 19th 2009, when the first RESPECT Index was announced, until December 2014, the Index generated a 70% rate of return.
For further information, please contact:
Pelion S.A. Press Office
Phone: (+48 42) 200 75 94
Fax: (+48 42) 200 75 35
Email: biuro_prasowe@pelion.eu
Pelion S.A. has operated on the market for twenty-five years, starting out as a local pharmaceutical wholesaler. In 1998, the Company shares were floated on the Warsaw Stock Exchange. Proceeds from the initial public offering fuelled the Company’s dynamic growth and allowed it to embark on consolidation of the pharmaceutical wholesale market. Since its flotation, the Company has secured a top position among domestic distributors of medicinal products. Today, Pelion Healthcare is one of the largest groups operating in the healthcare markets in Poland and Lithuania. It provides services across all market segments (wholesale, retail sales and sales to hospitals), targeted at individual patients, pharmacies, hospitals, and manufacturers. As a holding company, Pelion S.A. oversees all areas of the Company’s operations, which are conducted by PGF S.A. and Pharmapoint Sp. z o.o. (wholesale), PGF Urtica Sp. z o.o. (hospital sales), CEPD N.V. (retail sales), and Pharmalink Sp. z o.o. (services for manufacturers).
